Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851862 · ClinicalTrials.gov registry record
A Natural History of Late Onset Tay-Sachs Disease
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 10
- Enrollment target
NCT02851862: Completed study, sponsored by Massachusetts General Hospital.
NCT02851862 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02851862 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the natural history of Late Onset GM2 Gangliosidosis (Tay-Sachs disease and Sandhoff Disease) to inform future clinical trials.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-04 |
| Est. Completion | 2025-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02851862
The ClinicalTrials.gov registry entry for NCT02851862 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02851862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02851862 about?
NCT02851862 is a clinical study titled "A Natural History of Late Onset Tay-Sachs Disease". The purpose of this study is to learn more about the natural history of Late Onset GM2 Gangliosidosis (Tay-Sachs disease and Sandhoff Disease) to inform future clinical trials.
What is the current status of trial NCT02851862?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2016-04. Estimated completion is 2025-12.
Who is sponsoring clinical trial NCT02851862?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.